Investor Alert: Pomerantz Law Firm Investigates Medline Industries for Potential Securities Fraud

Pomerantz LLP is investigating potential securities fraud or unlawful business practices by Medline Industries, Inc. (NASDAQ: MDLN) and its officers following an FDA warning letter regarding manufacturing violations. The news caused a 7.16% drop in the company's stock price on June 2, 2026.

By Pomerantz LLP · PR Newswire · July 9, 2026, 21:32 UTC

Tickers: $MDLN

Topics: regulatory violation securities fraud stock price drop

Read the full article at PR Newswire

More World news

Barclays Upgrades Steel Producers Cleveland-Cliffs and Reliance Amid Market Selloff Seeking Alpha · November 12, 2026, 19:32 UTC
Mercantile Bank Announces New Full-Service Banking Center in Holland, Michigan PR Newswire · November 12, 2026, 19:28 UTC
Broadwind Reports 48% Revenue Growth and Record Industrial Solutions Backlog in Q3 2026 Motley Fool · November 12, 2026, 19:25 UTC
MediWound Reports Q3 2026 Financial Results Amid Clinical Trial Expansion Motley Fool · November 12, 2026, 19:25 UTC
Twist Bioscience Reports Q4 2026 Revenue Growth and First Positive Adjusted EBITDA Motley Fool · November 12, 2026, 19:25 UTC
Chicago Atlantic BDC Reports Q3 2026 Growth in Net Investment Income and Record Portfolio Value Motley Fool · November 12, 2026, 19:25 UTC
Google Integrates Gemini 4 Hydrogen Model into Search to Enhance Complex Query Handling TechCrunch · November 12, 2026, 19:27 UTC
General Motors Partners with NorthStar Clean Energy for Large-Scale Solar Project in Michigan Seeking Alpha · November 12, 2026, 19:24 UTC
CNBC Select Names Accredited Debt Relief Best for Debt Resources PR Newswire · November 12, 2026, 19:25 UTC
CorMedix Announces Acquisition of Heron Therapeutics Assets to Drive Revenue Growth Seeking Alpha · November 12, 2026, 19:20 UTC